Sophiris: Upcoming Release For Top Line Data In Phase 2b Prostate Cancer – Seeking Alpha


    Seeking Alpha

    Sophiris: Upcoming Release For Top Line Data In Phase 2b Prostate Cancer
    Seeking Alpha
    Sophiris top line data for Phase 2b study of Topsalysin in prostate cancer at end of 2Q18. Successfully tested in one Phase 3 clinical trial for BPH and a Phase 2a clinical trial for localized prostate cancer. Approximately 161,000 men will be

    Read more: seekingalpha.com

    SHARE

    LEAVE A REPLY

    Please enter your comment!
    Please enter your name here